PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “THROMBOSIS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,585 records · Page 88Linked to original sources

Incidence of deep vein thrombosis in postoperative hip fracture patients in Phramongkutklao Hospital.

BACKGROUND: There are many reports about deep vein thrombosis from Western regions but few reports are from Asian countries especially Thailand. OBJECTIVES: The purpose of the present study was to reveal the incidence of deep vein thrombosis in postoperative hip fracture patients. MATERIAL AND METHOD: Ninety six patients who had intertrochanteric fracture or femoral neck fracture were included. They had fixation or hemiarthroplasty performed according to their indications. Bilateral Venography was performed on the sixth to tenth day after surgery. RESULTS: The positive venography result was 47.9%. Only nine patients with positive results had signs and symptoms of deep veins thrombosis. Distal DVT was found in 43.5% of the positive group. Proximal DVT was 56.5%. No patients had symptoms of pulmonary embolism. CONCLUSION: The incidence of deep vein thrombosis in Thailand is the same as in Western countries. The prophylaxis regimen may become a part of the line of management in elderly patients with hip fracture. Further studies about the natural history or complications of deep vein thrombosis should be of concern.

Aged↗

Extensive upper extremity arterial thrombosis as the initial manifestation of nephrotic syndrome.

The metabolic derangement and resultant hypercoagulable diathesis associated with nephrotic syndrome (NS) has been clearly defined. Although venous thrombosis is frequently encountered in NS, arterial thrombosis is rare. This report describes an index case of a patient without known renal disease who presented with spontaneous arterial thrombosis of an upper extremity as the initial manifestation of NS. The case was complicated by subsequent deep venous thrombosis and pulmonary embolus in the absence of a patent foramen ovale. The patient was successfully treated with brachial artery thrombectomy followed by anticoagulation and immunosuppressive therapy. A renal biopsy was considered, but this would have required interruption of anticoagulation. This case illustrates the importance of performing a simple screening urinalysis for occult protein in patients with unexplained venous or arterial non-embolic thrombosis.

Adult↗

[Central venous catheter-related thrombosis with infection in cancer patients--2 cases].

Cancer patients receive intensive chemotherapy by central venous catheter (CVC). Generally, there is a major risk of CVC-related thrombosis and infection due to their hematological and immunological status, respectively. Recently, catheter-induced thrombosis caused by CVC-related bloodstream infection (BSI) has drawn attention in cancer patients. We observed a cohort of patients who received central venous catheterization for one year and described 2 cases of severe thrombosis associated with catheterization and its related infection. In both cases, neutropenic fever was followed by extended subcutaneous swelling with tenderness around the CVC-inserted site after intensive chemotherapy for malignant lymphoma. Chest CT revealed more severe thrombosis around the subclavian and cervical veins, but no mural thrombus on the contralateral site, in both cases. The thrombus included the air cavity, and was thought to be a sign of septic thrombi. Although the issue of the mechanism of infectious thrombosis associated with CVC insertion was not fully addressed, this rare but severe complication of CVC insertion should be studied descriptively and prevented by identification of risks and clinical signs.

Bacteremia↗

[Deep-vein thrombosis and pulmonary embolism due to air travel].

In recent years, the association between air travel and the incidence of deep-vein thrombosis or pulmonary embolism has become clearer. Epidemiologic studies reveal an increased relative risk of thromboembolism after flights of more than 8 hours and especially in subjects at higher risk for this disease, due, for example, to congenital thrombophilia or the use of oral contraceptives. However, the absolute risk of deep-vein thrombosis or pulmonary embolism after prolonged air travel is very small. Studies have shown that a combination of factors present during prolonged air travel may account for increased activation of coagulation. There is no definitive proof that elastic stockings are effective in reducing the incidence of clinically relevant thromboembolism during air travel. Acetylsalicylic acid is not effective in the prevention of thrombosis during air travel and may be dangerous. Prophylactic subcutaneous low molecular weight heparin may be effective to prevent air travel-associated thrombosis. However, pending more solid evidence, this strategy should only be used cautiously, e.g. only in patients with a high risk of thrombosis who are planning a long flight.

Aerospace Medicine↗

[Factor VIII and the risk of arterial thrombosis].

The pathomechanism of acute complications of atheromatosis, i.e. arterial thrombosis, still remains unclear. Conventional cardiovascular risk factors can explain only about 50% of cases of arterial thrombosis. The activation of intrinsic and extrinsic pathways of the coagulation system on damaged atherosclerotic plaque is one of the most important mechanisms. The role of clotting factors in the development of arterial thrombosis is also considered. From among a few clotting factors (V, VIII, XIII), factor VIII arouses interest due to the well-known observation that the morbidity for cardiovascular reasons is less among hemophiliacs than in the general population. A high factor VIII level predicts the occurrence of episodes of venous thromboses, but its role in the pathogenesis of arterial thromboses is still unclear. In clinical studies, a high factor VIII level predicts episodes of stroke, myocardial infarct, and acute lower-limb ischemia over a short period of observation. A high factor VIII level may the cause of about 5% of all episodes of arterial thrombosis. The reasons for elevated factor VIII levels in some persons remain unclear. Although heritability can play an important role, the influence of other factors (e.g. activation of the sympathetic nervous system) has been reported. The pathomechanism is the subject of investigation as well. An explanation for the occurrence of severe complications of arterial thrombosis in patients without significant risk factors may result in the development of methods of detection and prevention.

Atherosclerosis↗

Neonatal aortic thrombosis.

Thrombosis of the aorta in the neonate is a potentially catastrophic event. The incidence of this problem has increased concomitantly with the widespread use of umbilical artery catheters in the management of infants who are critically ill. The natural history and appropriate management of this complication has not been well established. This is due in part to the wide spectrum of presentations and lack of consensus regarding its classification. Aortic thrombosis may vary from deposition of a fibrin sheath surrounding the length of an umbilical artery catheter to aggregates of nonocclusive thrombus within the aorta or to complete occlusion of the aorta and concomitant occlusion of its main branches. The reported treatments recommended for this problem have ranged from supportive care only to mandatory surgical intervention in all cases. This spectrum of advocated therapies has resulted in considerable confusion regarding the proper management of this problem. This paper presents two cases of neonatal aortic thrombosis: one case was treated medically and the other case was treated with surgical intervention. We review these cases and the current literature, with specific attention directed towards highlighting the critical elements involved in formulating a reasonable approach to the management of neonatal aortic thrombosis. In addition, we offer an algorithm for management of these patients according to the degree of aortic thrombosis, severity of systemic manifestations, and the general condition of each individual patient.

Aortic Diseases↗

[Antiphospholipid antibodies--antiphospholipid syndrome. Cause or consequence of thrombosis].

Antiphospholipid antibodies (APA) are heterogeneous immunoglobulines of G, M or A classes with specificity directed towards anionic phospholipids. The APA are associated with a wide variety of diseases. They have been found to represent risk factor for development of arterial and/or veinous thrombosis. The APA would perturbed the biological activities of anionic phospholipid surface in a manner that could decrease the natural anti-coagulant pathway in order to lead to thrombosis. In the latter hypothesis APA would appear as a secondary response to the exposure of phospholipid "self antigens" by activated or damaged blood vascular cells by known stimuli able to induce thrombosis. In these cases APA would therefore constitute a marker of risk of thrombosis. The question which remains to be solved is if APA possess their own pathogenic potential or if they appear as the result of an up-stream pathological event known to be favourable to the development of thrombosis or if both mechanism are involved.

Antiphospholipid Syndrome↗

[Molecular basis of thrombosis].

Tremendous progress have been performed during the last 25 years in thrombosis. Thrombotic disease can result either from increased deposition or decreased dissolution of fibrin. Since the first observation of a familial antithrombin III deficiency, numerous inherited defects of antithrombotin III, protein C, protein S, heparin cofactor II and plasminogen have been described and were assumed to be responsible of a thrombophilic state. However a disparity in the clinical expression of heterozygous deficiency in coagulation inhibitors or molecular abnormalities of coagulation does exist. On one hand, the prevalence of such molecular diseases is not yet perfectly known and on the other hand, contributory factors (acquired environmental insults or other genetic abnormalities) could play a role in individuals already predisposed to thrombosis. The molecular genetics of deficiencies is going to help us to establish specific gene lesions and thromboembolic history relationships. The analysis of structural or regulatory mutations in the genes of the different coagulation inhibitors, of the molecules of the fibrinolytic system, and of the fibrinogen molecule will greatly increase our knowledge of the molecular basis of thrombosis. The influence of the genetic polymorphism of these molecules on the risk of thrombosis should be studied. Finally, cellular aspects of thrombosis including the role of blood cells and endothelial cells will bring lot of informations on the comprehension of thrombotic diseases.

Blood Cells↗

[Thrombosis of renal veins].

According to whether they are acute or progressive, complete or partial, uni- or bilateral, renal venous thromboses have quite various clinical expressions and biological consequences. The diagnosis is readily suggested by acute pain in the side with an increase in the size of one or both kidneys, associated with hematuria, proteinuria, or in case of renal failure, which is characteristic of acute bilateral thrombosis. On the other hand, chronic thrombosis of a renal vein is sometimes suggested only when complications such as pulmonary embolism occur. This explain why it is often discovered on autopsy. The diagnosis is confirmed on the basis of radiology, with ultrasound combined with vascular Doppler becoming increasingly important. Renal venous thrombosis may have various causes: disorders in renal blood flow, especially in the acute forms in newborns; hypercoagulability, in particular in nephrotic syndromes and above all in extramembranous glomerulonephritis; extension of vena cava thrombosis; retroperitoneal diseases involving the renal pedicle or extension of a renal tumor. The treatment of renal vein thrombosis is mainly medical and based on anticoagulants. The role of fibrinolytic treatment is controversial. Surgery is exceptional.

Humans↗

[Aseptic cerebral sinus thrombosis. 5 cases and a review].

From 1988 to 1990, we observed five cases of aseptic dural sinus and cerebral venous thrombosis, all in non-smoking women (age 18 to 47 years) receiving low dose oral contraceptives. Treatment consisted of full anticoagulation over 2 to 6 months, over which time the neurologic symptoms disappeared almost completely. Extensive tests of the blood clotting system in 4 patients after 6 to 19 months revealed a reduction of free protein S in 2 patients with a history of contraceptive use over several years, and normal results in 2 patients in which the sinus thrombosis occurred within the first 6 weeks of use of the oral contraceptive. Whether the protein S deficiency was congenital or caused by the oral contraceptive cannot be decided retrospectively. Even modern oral contraceptives seem to lead to an increased incidence of sinus thrombosis. Initial symptoms of sinus thrombosis include headache and somnolence, followed either by focal neurologic deficits (often associated with focal seizures) or by signs of increased intracranial pressure. CT scans show venous infarcts or general brain edema and may specifically show the "empty triangle sign" and "delta sign". The CT scan may also be normal if focal neurologic deficits are absent. MRI is favoured as it can directly show the thrombosed sinus or veins. Differential diagnosis includes arterial stroke, brain tumor, encephalitis or "benign intracranial hypertension", which should only be diagnosed after sinus venous thrombosis has been appropriately ruled out. Recently, full anticoagulation has been recommended as therapy.

Adolescent↗

[Cerebral sinus vein thrombosis in Behçet's disease].

A 20-year-old Turkish patient presented with superior sagittal sinus thrombosis which led to the final diagnosis of Behçet's disease. The frequency of cerebral venous thrombosis is generally underestimated and may be the first clinical manifestation of Behçet's disease. Uveitis as a main diagnostic criterion of Behçet's disease may be absent, especially in young men. In cases of intracranial hypertension, cerebral venous thrombosis and Behçet's disease should be taken into consideration, especially in a high risk population from eastern Mediterranean countries and Japanese islands. Treatment with early anticoagulation in cerebral venous thrombosis, and corticosteroid-pulse therapy in active Behçet's disease, seems to be established today. As a basic therapy of Behçet's disease cyclosporin A and the classic immunosuppressive agents, especially azathioprine, are available. Clinical course and prognosis in cerebral venous thrombosis are generally both benign, provided that adequate management is started in time.

Adult↗

[Thrombosis of the superior cerebral vein with hemorrhagic cerebral infarction--serial MRI and pathological study of a case].

We reported an autopsy case of thrombotic occlusion of the superior cerebral vein with hemorrhagic laminar necrosis of the right parietal cortex. A 68-year-old woman was admitted to our hospital because of a severe headache and left hemiplegia of acute onset. There was a past history of hypertension, fever of unknown origin, leukocytopenia and nasal dermatitis. Magnetic resonance images (MRI) disclosed thrombosis of the superior sagittal sinus and of the right parietal cortical vein as well as right parieto-occipital cerebral infarction. Although she improved with mild sequelae, the subsequent MRI showed a recurrent thrombosis of the superior sagittal sinus. Ten months after the onset she died suddenly, presumably due to acute myocardial infarction. Pathologically, thrombotic occlusion of the right parietal cortical vein, recurrent thrombosis of the superior sagittal sinus and old hemorrhagic cortical laminar necrosis of the right parietal region were revealed. Moreover, intracranial arteritis and phlebitis were observed, as well as arteriolitis in the peripheral nerves. In our case, MRI was useful for the diagnosis and following the course of cerebral venous thrombosis. Cerebral noninfective vasculitis may well have caused the venous thrombosis.

Aged↗

Mesenteric venous thrombosis caused by deficiency of physiologic anti-coagulants: report of a case.

Mesenteric venous thrombosis is a clinical entity, which is rarely recognized on admission. The patients are admitted with vague abdominal complaints and, eventually, abdominal sepsis might occur requiring laparotomy. Nowadays, underlying hypercoagulable states such as antithrombin-III, protein-C and protein-S deficiencies are recognized more frequently as a distinct cause of mesenteric venous thrombosis. In this paper, a case of mesenteric venous thrombosis due to protein-C deficiency is presented. The patients generally have a history of thromboembolism of the deep veins of the legs at young age. The combination of vague abdominal complaints and a history of thrombosis of the deep veins of the legs should arouse the suspicion of mesenteric venous thrombosis. In these cases, contrast-enhanced computerized tomography is a non-invasive diagnostic means which may provide the diagnosis. If infarction of the gut is present, resection is mandatory and a second-look operation should be performed. After surgery, heparinization is essential. This must be followed by administration of oral anticoagulants for an indefinite period in case of an underlying antithrombin III, protein-C or protein-S deficiency.

Adult↗

External carotid artery embolization of dural arteriovenous malformations involving the cavernous sinus. Outcome and role of venous thrombosis.

Nine patients with dural arteriovenous malformations (AVMs) in the region of the cavernous sinus were treated by means of external carotid artery (ECA) embolization using polyvinyl alcohol. All AVMs received vascular supply from both the ECA and the internal carotid artery. Seven cases were clinically cured after embolization, while 2 cases with cortical venous drainage and high flow through the shunt were not completely cured. Venous thrombosis was observed in 5 cases before and in 9 after embolization. In 6 cases the drainage pattern changed owing to venous thrombosis. Complete thrombosis of the cavernous sinus was found on a follow-up angiography in 2 cases. Formation of venous thrombosis and occlusion of feeding arteries are crucial factors for success of ECA embolization. Dural AVMs with cortical venous drainage and high flow cannot be relieved by ECA embolization alone owing to difficulty in obtaining thrombosis of the veins.

Adult↗

Tunneled catheter thrombosis: factors related to incidence.

Quasi-experimental and descriptive methods were used to investigate thrombosis incidence in 294 tunneled central venous catheters inserted in adult clients with cancer. Thrombosis incidence was measured in relation to heparin flush regimen, internal catheter tip location, and chemotherapy infusate volume. Data were collected for two cohorts: 1) 145 tunneled catheters using 5 ml daily of 10 U/ml heparin flush, and 2) 51 catheters using 10 cc daily of 100 U/ml heparin flush. Data were also collected for an additional 98 catheters (transitional) utilizing a combination of flush #1 and #2 from adjacent time periods. Chi square analysis of the cohorts revealed no difference in thrombosis incidence by flush regimen or chemotherapy infusate volume. Suboptimal internal catheter tip location and catheters placed on the left side were related to higher thrombosis incidence. Practice implications include: the need for staff and patient education regarding signs and symptoms of catheter-related thrombosis, additional systematic data collection and evaluation, and support for empirical research to establish optimal vascular access device care.

Antineoplastic Agents↗

[Treatment with urokinase of systemic arterial thrombosis in the newborn infant].

The records of 5 neonates with systemic arterial thrombosis (aortic in one case, peripheral in four cases) were reviewed. Fibrinolysis was performed with urokinase administered by infusion (1,000 to 4,000 U/kg/h). This treatment was combined with heparin therapy in 4 cases. Thrombosis was due to various causes: umbilical arterial catheter (1 case), disorders of supraventricular rhythm in utero (1 case), aneurysm of the ductus arteriosus with dysplastic aortic arch vessels (2 cases); one of these patients also had myocardiopathy. No cause could be found in a premature child weighing 1,300 g. The presenting symptoms of systemic arterial thrombosis are ischaemia of the extremities and suppression of peripheral pulses; heart failure with arterial hypertension is frequent. In our series the diagnosis was confirmed by doppler-ultrasonography in one case and by angiography in three cases (angiography in the left ventricule with foramen ovale, or umbilical aortography). Treatment with urokinase lasted 1.5 to 7 days. In 2 children the initial dosage had to be increased as there was no clinical improvement. Four children were completely cured; the fifth child, who had left renal thrombosis, shows slight functional impairment of the left kidney. There were no haemorrhagic complications. The fibrinolytic treatment with urokinase of systemic arterial thrombosis in the newborn is effective and has few drawbacks.

Angiocardiography↗

Thrombosis in particular organ veins.

Renal vein thrombosis in early infancy is a complication of dehydration and prolonged hypotension. The onset is usually acute and the most common clinical signs are uni- or bilateral frank masses, hematuria, proteinuria and thrombocytopenia. In most cases, with conservative management, the late outcome is favorable. In the adult, renal vein thrombosis is often a silent complication of the nephrotic syndrome, the hypercoagulability of which may be an important factor in the pathogenesis of the thrombosis. Clinically, the presentation of a sudden complete occlusion is that of severe abdominal and lumbar pain with hematuria and loss of function of the kidney that suffers hemorrhagic infarction. Physical examination often reveals an enlarged kidney. With gradual occlusion, renal function is preserved. The initial diagnostic approach is with ultrasound studies and computed tomography; definitive diagnosis is established by renal venography or by selective renal arteriography. In general, a conservative approach including the use of anticoagulant treatment is preferred to surgical intervention. Priapism is a persistent painful penile erection due to ischemic or non-ischemic causes; therapeutic intracavernosal injection of papaverine is becoming the most common cause. In early and mild stages, aspiration of blood from the corpora cavernosa supplemented with intracavernosal irrigation with alpha-stimulating agents is the procedure of first choice; in late and severe ischemia, a shunt procedure may become necessary. Hepatic vein thrombosis occurs in association with a number of conditions considered predisposing factors including the use of oral contraceptives. The clinical picture may be that of an acute illness with abdominal pain, hepatomegaly, ascites and hepatic failure as well as early death. More often, the onset is insidious with slowly developing ascites and wasting. For the diagnosis, hepatic scintigraphy may be helpful but, at present, ultrasonography, computed tomography and magnetic resonance scanning are procedures of choice. There is, as yet, no adequate treatment. A fatal outcome may be prevented by surgical decompression of the congested liver and, in recent years, liver transplantation has been employed. Portal vein thrombosis, in children, is usually considered a complication of umbilical sepsis or a result of a congenital abnormality of the portal vein. In adults, the most frequent causes are hepatic cirrhosis and neoplasia. Clinically, there may be a sudden appearance of ascites with resolution in a symptom-free interval until the onset of other features of portal hypertension occur. Currently, ultrasound real-time imaging supplemented with Doppler capability, computed tomography and magnetic resonance scanning provide the necessary diagnostic information. Variceal hemorrhage is often the first major complication requiring treatment.(ABSTRACT TRUNCATED AT 400 WORDS)

Budd-Chiari Syndrome↗

[Ultrasonic diagnosis of deep venous thrombosis. A comparison with venography].

In a prospective study ultrasonography (US) was compared with venography for diagnosis of deep venous thrombosis of the leg. Using venography, thrombosis was demonstrated in 25 patients. Based on two criteria, non-compressible vein and intraluminal echoes, US showed thrombosis in 23 patients, i.e. the sensitivity was 92%. Isolated calf vein thrombosis was demonstrated in 2 out of 4 patients. In 18% of the patients with negative venography other pathological conditions were demonstrated by US, (i.e. Baker's cysts, calf vein hematomas and superficial calf vein thrombosis) which could explain the clinical condition. Venography is a somewhat costly procedure. The cost of films and non-ionic contrast medium is approximately NOK 400, while the cost of film for US examination is about NOK 10.

Adolescent↗